AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CHLORPHENIRAMINE MALEATE BP
4 registrations across 3 African markets— 2 active
Markets with CHLORPHENIRAMINE MALEATE BP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CPM tablets Tablet Uncoated | 🇿🇲Zambia | Dawa Limited | active | Aug 2030 |
| DAWA-CPM TABLET Tablets | 🇷🇼Rwanda | Dawa Limited | active | Aug 2029 |
| FENAMINE 4MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2024 |
| ALLESTON 2MG/5ML SYRUP SYRUP | 🇲🇼Malawi | — | expired | Jun 2014 |
CHLORPHENIRAMINE MALEATE BP in Africa — Regulatory Overview
CHLORPHENIRAMINE MALEATE BP is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Rwanda, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 2 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.